October 9, 2025/
This issue of New Zealand's Prescriber Update provides critical safety information and regulatory updates for healthcare professionals, 46(3) September 2025.
ALVigiLance is a dedicated pharmacovigilance platform designed to support the healthcare team in ensuring safer medication use. Our mission is simple yet vital: to provide trusted insights, practical tools, and up-to-date resources that empower healthcare professionals to identify, prevent, and manage adverse drug reactions (ADRs).
Simplified, practical guides on drug safety and monitoring.
Real-world examples to strengthen your clinical decision-making.
Summaries of global drug warnings and regulatory actions.
Strategies for adverse event reporting, risk management, and patient counseling.
To create a proactive community of healthcare providers who champion medication safety and improve patient outcomes through shared knowledge and vigilance.
Medication safety is everyone’s responsibility. Explore, learn, and engage with ALVigiLance — because together, we can reduce risks and save lives.
This issue of New Zealand's Prescriber Update provides critical safety information and regulatory updates for healthcare professionals, 46(3) September 2025.
Vaccinovigilance is a specialized branch of pharmacovigilance focused exclusively on vaccines. The term is widely used, particularly in French-speaking countries and in international health contexts, and it is entirely...
These are the official bodies in each country where you can report suspected side effects of medicines, vaccines, and quality issues.
